Načítá se...
Genotype-driven therapeutic developments in Parkinson’s disease
BACKGROUND: Remarkable advances have been reached in the understanding of the genetic basis of Parkinson’s disease (PD), with the identification of monogenic causes (mPD) and a plethora of gene loci leading to an increased risk for idiopathic PD. The expanding knowledge and subsequent identification...
Uloženo v:
| Vydáno v: | Mol Med |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8056568/ https://ncbi.nlm.nih.gov/pubmed/33874883 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10020-021-00281-8 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|